Skip to main content
Aligned Genetics, Inc. logo

Aligned Genetics, Inc. — Investor Relations & Filings

Ticker · 238120 ISIN · KR7238120000 KO Manufacturing
Open in API
Filings indexed 140 across all filing types
Latest filing 2022-12-16 Regulatory Filings
Country KR South Korea
Listing KO 238120

About Aligned Genetics, Inc.

https://en.alignedgenetics.com

Aligned Genetics, Inc. is a company that develops, manufactures, and sells advanced solutions for cellular imaging, biomolecular analysis, and molecular diagnostics. It provides cutting-edge equipment, automated systems, imaging instruments, and reagents for laboratories in the life science and medical fields. The company focuses on developing molecular diagnostic solutions that deliver rapid and accurate results to support faster clinical care. Aligned Genetics aims to improve human health by creating technologies that offer deeper insights into cellular and molecular processes.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure period for an upcoming Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal regulatory notice of the procedural steps for the meeting. Given it is a standard regulatory announcement regarding corporate governance procedures, it fits best under the RNS category.
2022-12-16 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Aligned Genetics' (주식회사 얼라인드제네틱스) covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial information, business operations, and management discussions, which is characteristic of an interim/quarterly financial report. 9M 2022
2022-11-14 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-annual Report) for Aligned Genetics, covering the period from January 1, 2022, to June 30, 2022. It contains detailed financial data, business descriptions, and management information, which fits the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-16 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Aligned Genetics' covering the period from January 1, 2022, to March 31, 2022. It contains detailed financial information, business operations, management discussion, and capital structure, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-16 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과). It details the approval of financial statements, board appointments, and other resolutions passed during the meeting held on March 28, 2022. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2022-03-28 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the appointment of an outside director (Sun Woong) at Aligned Genetics, including his background and term. This falls under the category of board and management changes.
2022-03-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.